A newly established nonprofit organization aims to “transform” the end-of-life experience through the therapeutic use of psychedelics. The stated mission of Florida-based End of Life Psychedelic Care (EOLPC) is to educate health care providers, policymakers and the public as well as foster access to those substances for terminally ill patients. “Everyone deserves compassionate care as […]
Rep. Earl Blumenauer (D-Ore.) has introduced a bill that would allow some end-of-life patients to use psilocybin and other investigational treatments. The Right to Try Clarification Act would revise a current law that was designed to give access to experimental treatments to dying patients who have exhausted other options. The proposed bill would add Schedule […]
U.S. Senators Cory Booker (D-N.J.) and Rand Paul (R-Ky.) have introduced a bill designed to give terminally ill patients access to certain controlled substances. If enacted, the bill would clarify that patients receiving end-of-life care could access Schedule 1 controlled substances that have undergone a Phase 1 clinical trial, including MDMA and psilocybin. Reps. Earl Blumenauer […]
Psychedelic medicines may represent a new frontier for end-of-life care, as well as psychiatric treatment. While these substances — including LSD, MDMA, psilocybin and ketamine, among others — remain illegal, grass roots support for decriminalization or medical use is growing. Meanwhile, venture capitalists and other investors are spending billions to get on the ground floor […]
Demographic populations that historically have been underserved by hospice are also among the most severely impacted by the COVID-19 pandemic. Members of the African American, Hispanic and Native American communities have been disproportionately represented in the numbers of COVID infections and associated mortality. U.S. counties with a predominantly African American population, for example, tend to […]
In addition to rising demand for hospice and palliative care among COVID-19 patients themselves, the pandemic is affecting the way clinicians provide those services to people with other conditions, such as cancer, according to a recent editorial in the Journal of the American Medical Association-Oncology. Palliative care teams have had to reexamine their methods of […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
